Lung
Colon
Pancreatic
Breast
Bone
Brain
Ovarian
Leukemia
Prostate
Liver
                   

Welcome to CytoLuminator, the only 4th generation photodynamic therapy providers.

Research Papers on Photodynamic Therapy and Cancer and Immunity

Size: Name:
801.919   (ANTI-Fs) ANTIBODIES Changes in Ca patients.pdf
728.574   (COX-2) plays a crucial role in Helicobacter pylori-associated gastric cancer.pdf
1.303.612   1 - Immunity.pdf
537.000   1-ALA CA.pdf
350.506   2 - Oxidative stress.pdf
86.448   3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects..pdf
85.035   3-Bromopyruvate inhibits calcium uptake by sarcoplasmic reticulum vesicles but not SERCA ATP hydrolysis activity.pdf
83.012   3-Bromopyruvate targets and outcomes.pdf
1.236.281   3BP Case Report_JBB_ 96_Jan 19_2012.pdf
420.883   3BP targets.pdf
662.137   5-HALO-&PHENYL PYRIMIDINONES IFN induction and NK.pdf
387.164   A Breakthrough Against Leukemia Using Altered T-Cells - NYTi.pdf
97.858   A Review of Progress in Clinical Photodynamic Therapy.pdf
303.660   A time-res conc quench of disulfonated aluminium phthalocyanines.pdf
116.823   Access _ STATs in cancer inflammation and immunity_ a leading role for STAT3 _ Nature Reviews Cancer.pdf
181.956   acidosis improves antigen uptake.pdf
100.962   action spectrum HIV.pdf
367.990   Activation of the IL-10 Gene Promoter Following Photodynamic Therapy of Murine Keratinocytes.pdf
145.839   acute-phase-response-systemic-neutrophil-mobilization-mice-pdt.pdf
588.576   Ad-sig-TAA ecdCD40L vector epithelial cancer.pdf
598.615   adaptive-immunity-maintains-occult-cancer-equilibrium.pdf
88.828   Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity.pdf
483.910   Ag Inhib of CD8+ Tcell response mediated by ROSs.pdf
832.598   Ags and Abs in PATHOLOGIC SERA AND TISSUES.pdf
87.294   AKBA colon ca.pdf
258.914   akba dosage 50 200 mg per kg.pdf
101.071   ala abstract.pdf
120.366   ALA autoimmune skin ulcers.pdf
159.591   ala esophogeal.pdf
225.544   ala glioma.pdf
1.524.075   ALA pdt leukemia 6 cell lines.pdf
148.112   Alemtuz.pdf
1.115.785   Alemtuzamab.pdf
228.427   alemtuzumab-for-lymphoid-malignancies.pdf
466.850   AlNaPc synthesis tuning 900 nm.pdf
1.067.896   ALPC BIODISTRIBUTION.pdf
465.168   AlPc brain colon and pancreas.pdf
1.647.564   AlPc Glioma.pdf
138.152   AlPc imaging fluorescence.pdf
62.166   AlPc Macular degeneration clinical tria.pdf
613.245   AlPc microbial.pdf
545.884   AlPc saturation pulsed laser.pdf
613.245   AlPc substituents.pdf
643.794   AlPc ZnPc liposomes.pdf
1.448.385   alpc-pdt-experimental-malignant-glioma.pdf
5.989   AlPcS vs other metals.pdf
323.029   AlPcS2 660 nm MRSA.pdf
123.768   AlPcS2 absorp in vivo change with activation and time.pdf
505.805   AlPcS2 biotin.pdf
166.444   AlPcS2 triplet state photophysics.pdf
778.042   AlPcS2 vs S4 glutathione concentrations.pdf
563.529   AlPcS4 vs AlPc phototoxicity.pdf
100.362   alpha beta TCR+ T cells.pdf
327.680   alpha tocopheryl succinate apoptosis breast Ca.pdf
920.037   alteration-plasma-lipoproteins-cremophor-el.pdf
183.742   Aluminum toxicity.pdf
56.189   American Cancer Society Admitted That Untreated Cancers Often Go Away Naturally .pdf
835.099   amphi chito micelles.pdf
164.759   amphiphilic tetrasulfonates.pdf
744.282   ankylosing.pdf
287.331   anti bacterial viral pdt sensitizer list.pdf
775.017   anti il-10.pdf
896.326   ANTI-CD3 PLUS IL-2.pdf
219.849   anti-CD40 and IL-2 complete regression of metastasis.pdf
179.444   anti-CTLA-4 Ab plus anti-CD25 Ab deplete Tregs induce tumor rejections.pdf
1.294.165   Anti-ErbB-2 mabs.pdf
574.640   Anti-IL-10 augments resistance to bacteria.pdf
818.871   Anti-IL-10 suppresses antigen specific Tcells.pdf
297.346   Anti-IL-10 tapeworm effect.pdf
60.711   Anti-IL-10 Tolerance Induction by Anti-CD2 Plus Anti-CD3.pdf
502.767   Anti-p53 Fab CoCa.pdf
226.639   antiangiogenic-pdt-visudyne-suppression-tumor-growth.pdf
344.156   Anticancer Activity of the Antibiotic Clioquinol SOD inhibition.pdf
221.410   antifungal-pdt.pdf
243.931   Antigen Recognition and Age-Dependent Glioma Mortality.pdf
428.986   Antigen-Nonspecific Lymphoid Cells in immune mediated inflammation.pdf
1.316.275   antigen-specific-immunosuppression-cutaneous-pdt.pdf
219.896   antigen-specific-nonspecific-modulation-immune-response-ala.pdf
219.896   antigen-specific-nonspecific-modulation-immune-response.pdf
84.982   Antigenic Glycopeptide.pdf
367.068   Antigenic Peptide encoded by MAGE Genes.pdf
1.015.782   Antimicroial activity.pdf
1.575.217   Antioxidant Inhibitors Potentiate the Cytotoxicity of PDT.pdf
704.156   Antitumor Activity of IFN-gamma CD95 treg.pdf
950.272   antitumor vaccines using PDT.pdf
399.793   antitumor-conjugates-oncofetal-protein-phthalocyanines adjuvant 10-3.pdf
49.756   antitumor-efficacy-pdt-chemotherapy-murine-tumors.pdf
150.593   apoptosis vs necrosis nature immunology.pdf
487.160   apoptosis-mechanisms-sensitivity-jurkat-tcells-a431-epiderm.pdf
149.089   apoptosis.pdf
114.887   artemisinin 1.pdf
156.193   AS101 inhibition of IL-10 protects from sepsis death.pdf
293.949   ascorbate glycerol HIV.pdf
156.007   assessing-response-chemo-metastatic-melanoma-fdg-pet.pdf
373.065   attempts-measure-sensitiser-photophysics-opaque-tissue.pdf
204.462   Augmented interleukin (IL) -15Rα expression by CD40 activation is critical in synergistic CD8 T-cell mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.pdf
79.461   australian government.pdf
968.425   autoimmune.pdf
322.185   autophagy and its implication in cancer etiology.pdf
280.094   avidity.pdf
162.654   B cell mediated autoimmunity.pdf
1.543.677   B cells inflamation.pdf
594.262   B lymphocyte stimulator receptor.pdf
718.206   B7 (CD80) or anti-CD28-mab large tumor rejection.pdf
374.863   Bactericidal Effects of Toluidine Blue-Mediated Photodynamic Action.pdf
524.288   bacteriochlorphyl.pdf
258.756   barrett.pdf
342.755   basic-escalating-immunomodulatory-treatments-ms.pdf
249.093   Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy.pdf
374.833   bcl-2 loss apoptosis.pdf
318.723   Bcl-xl inhibition restores apoptotis.pdf
655.360   big sheet on PDT and GvHD.pdf
114.985   BING-4 cancer Antigen in complete regression.pdf
941.798   bio-nano hybrid theory.pdf
179.889   bio-nanotechnology-pdt.pdf
94.491   Bio-Plex Pro Human Cytokine 27-plex Ass.pdf
994.024   bioavailabilty of curcumin problems.pdf
130.338   biodistribution-znpc-plasma-lipoproteins.pdf
207.067   black tea.pdf
20.374   Bladder cancer in vivo complete remission.pdf
506.005   blocking natural and adaptive Treg.pdf
158.520   blood parasites phthalocyanines.pdf
1.244.065   bone rat and porcine.pdf
1.282.478   BOPP rat 635 nm.pdf
197.276   boronated Pc.pdf
1.017.755   boswellic acids.pdf
307.989   bowens squamous.pdf
297.049   brain apoptosis pdt sensitizer comparison.pdf
101.221   brain melanoma pdt.pdf
465.168   brain tumour.pdf
626.795   BrCa immune response to mutated EGF-R.pdf
1.006.354   BrCa intracellular Ag apoptosis.pdf
669.316   bright NK not so bright about cancer.pdf
155.610   Bromopyruvate mediates autophagy and car... [J Bioenerg Biom.pdf
35.700   bromopyruvate.pdf
259.834   Bryostatin-1 and IL-2 Synergize to Induce IFN-gamma.pdf
487.955   bso asc.pdf
291.170   Buckminsterfullerene and photodynamic viral treatment.pdf
333.323   buckminsterfullerine c60 viral inactivation.pdf
1.321.337   buryrate improves bromopyruvate.pdf
88.322   Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate..pdf
179.729   Ca-activated chloride channel 2 (CLCA2).pdf
86.598   Can Integrative Oncology Extend Life in Advanced Disease.pdf
323.073   cancer initiation stem cells.pdf
588.340   Cancer Testis Genes in Multiple Myeloma.pdf
75.167   cancer therapeutic to stimulate natural killer cells.pdf
472.180   Cancer-Testis Ag.pdf
513.972   CancerHydrogenperoxideLevine2005[2].pdf
112.063   Candidate Tumor Antigens in Colorectal Cancer.pdf
44.086   canine oral scc pdt.pdf
187.150   carobxymethyl chitosan.pdf
93.572   Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.pdf
1.334.368   cationc vs anionic tumor perfusion.pdf
327.632   cationic phthalocyanines 2.pdf
431.913   cationic ZnPc.pdf
820.536   CCR5.pdf
1.212.364   CD 40.pdf
591.240   CD200 Expression on Tumor Cells Suppresses Immunity.pdf
475.852   CD21 role in Extracellular HIV reservoir.pdf
203.558   CD27 required for T cell immunity.pdf
357.412   CD4+ Tcells activate by direct presentation of Ag not DCs.pdf
79.086   CD40.pdf
328.249   CD40L viral anticancer vaccine.pdf
1.064.940   CD8+ CD4+ T Cell Response to Ag NY-ESO-1.pdf
203.926   CD8+ T cell-mediated control of distant tumours following local photodynamic therapy.pdf
111.688   CD8+ Tcells IFN-gamma tumor dormancy.pdf
791.320   CD80 CD86 stim CD4+ CD8+ Tcells.pdf
335.493   CD95 kills Treg.pdf
848.181   CD95 Ligand-Induced Neutrophil Infiltration.pdf
745.796   CDLC_Speedlite430EXII_QuickGuide.pdf
277.488   ce6 chitosan.pdf
277.488   ce6 folic chitosan.pdf
230.298   Ce6 polylisine.pdf
366.731   cell death pdt apoptosis Bcl-2 autophagy.pdf
261.398   cell localization microbial.pdf
501.836   cell-corpse-engulfment-celegans-phosphatidylserine-receptor.pdf
230.342   Cellular and Humoroal Immune response p-53 lung cancer.pdf
929.889   ceramide apoptosis.pdf
930.076   cervical fluor.pdf
877.252   characterisation-3-substituted-znpc-differing-charge-pdt.pdf
189.290   characteristics-complement-activation-mice-lewis-lung-carcinomas-pdt.pdf
1.316.275   characteristics-immunosuppression-cutaneous-pdt.pdf
340.205   chelation inhibits cancer stem cells.pdf
49.756   chemo pdt leukemia.pdf
254.410   chest tumors.pdf
311.614   China study 540 cases HPD.pdf
675.319   chinese medical journal.pdf
459.507   Chitin, Chitosan, and Glycated Chitosan Regulate Immune Resp.pdf
166.975   Chitosan A Marine Medical Polymer.pdf
466.071   chitosan adipate hydrogel boosts cd4 cd8.pdf
168.295   chitosan and nucleic acids.pdf
866.282   chitosan biomaterials immune.pdf
600.799   chitosan cancer hepato.pdf
37.520   chitosan curcumin surface methodology.pdf
763.837   chitosan gel PS and antibiotic delivery.pdf
174.721   chitosan hydrophilic hexapeptide.pdf
166.774   chitosan immunotherapy.pdf
786.089   chitosan prep and antibacterial.pdf
538.954   chitosan unlimited applications.pdf
30.600   chitosan.pdf
240.827   chlorin e6 conjugate polylysine length identified.pdf
353.772   chlorin e6 PVP.pdf
1.460.438   Chloromethyl-X-rosamine (MitoTracker Red) photosensitises mitochondria.pdf
63.410   chloroquine cancer and viral.pdf
76.312   chlorosulfonic esterification of phenols jumps directly to disulfonation.pdf
361.129   circumin apoptosis.pdf
1.489.928   circumin nanoparticles.pdf
328.285   CKb-11 chemoattracts T cells, B cells, dendritic cells, macrophage progenitors, and NK cells BrCa.pdf
65.872   clinical-efficacy-mal-pdt-bcc-solar-keratosis.pdf
141.185   cliquinol TNF release frm macrophages.pdf
480.859   CMCS and linoleic acid.pdf
32.633   CNS CA cancer clin.pdf
312.254   COA 3BP.pdf
15.817   COA-Carboxymethyl_Chitosan EASTAR.pdf
131.317   CoCa CD40-L induces immunity.pdf
1.199.020   CoCa IMMUNOSUPPRESSIVE Factor.pdf
341.150   Coca Induce Lymphocyte Apoptosis.pdf
327.774   CoCa PGE2 Cox2 IL-1alpha.pdf
508.852   CoCa Tcell clone antigen.pdf
46.000   coenzyme_q10_part1.pdf
141.759   Colostrum-enhances-stem-cell-proliferation.pdf
66.469   Combination of hydrogen peroxide and low-frequency ultrasound exposure induces apoptosis in human ovarian cancer.pdf
281.728   common-nonmalignant-skin-conditions-adults-central-vict.pdf
1.383.602   comparative-study-cellular-uptake-pd-efficacy-3-novel-znpc.pdf
364.925   comparison-argon-dye-excimer-dye-pd-effect-mouse.pdf
367.353   comparison-pdt-topical-mal-cryotherapy-actinic-keratosis.pdf
359.122   comparison-phototoxicity-mech-pulsed-cw-pdt.pdf
474.366   complement-activation-cascade-regulation-response-tumors.pdf
189.290   complement-activation-mice-lewis-lung-carcinomas-.pdf
81.406   Complement-Dependent Cytotoxicity.pdf
287.941   comprehensive-overview-pdt-superficial-fungal-infections-skin.pdf
443.864   consequences-pdt-resting-activated-peripheral-t-cells.pdf
443.864   consequences-pdt-resting-activated-peripheral-t-lymphocytes.pdf
230.635   contribution-myeloid-lymphoid-host-cells-curative-outcome-mouse-sarcoma-pdt.pdf
829.241   converting-relapsing-remitting-secondary.pdf
294.799   copper transport.pdf
123.361   Copy of interleukin 10 in cancer patientsi.pdf
532.398   Counterattack Hypothesis Revisited.pdf
549.863   cox-2 Treg inhibition.pdf
51.031   cox2 cancer.pdf
272.710   cox2 inhib upregs IFN-gamma antitumor.pdf
827.112   COX2 inhibitors enhance BrCa vaccine.pdf
280.048   CpG Oligodeoxynucleotide.pdf
568.914   CpG PDT.pdf
1.378.268   ct antigens.pdf
769.379   CTL banned from lymphoid follicles HIV replication site.pdf
217.117   CTL by sc imiquimod.pdf
351.885   CTLA-4 blockade has mediated objective cancer regression.pdf
596.560   curcumin head and neck Ca.pdf
56.114   curcumin heat solubilized.pdf
893.605   curcumin polyvinylpyrrolidone.pdf
828.937   curcumin.pdf
209.671   cyclocextrin carrier photocleavable.pdf
1.061.553   CYTOLYTIC EFFECTOR CELLS in healthy and cancer patients.pdf
1.056.783   CYTOLYTIC EFFECTOR CELLS.pdf
240.753   cytonano.pdf
461.233   Cytotoxicity and mechanism of action of a new ROS-generating microsphere.pdf
573.505   Cytotoxicity of Fas Ligand.pdf
124.783   cytotoxicity signaling.pdf
190.446   dartmouth pulsed.pdf
471.183   dartmouth study pdt.pdf
477.967   DC Ag-loading.pdf
114.424   DC Vacc PrCa.pdf
179.596   DC vacc with chemo.pdf
290.193   DC's chemokine coreceptors hiv entry.pdf
789.511   dca hepatocarcinogenesis.pdf
422.674   DCs and Ag induce CTLs and immunity.pdf
404.561   DCs and Chemo.pdf
1.312.777   DCs recomb Virus and IFN-beta.pdf
293.939   ddc antimelanoma anti BrCa.pdf
933.888   DDC antioxidant.pdf
434.791   DDC dosage determines cytotoxicity.pdf
980.202   DDC inhibits apoptosis.pdf
598.841   DDTC oxidative stress.pdf
285.048   deaggregation of ZnPc Pyridine Fullerenes Guanasin.pdf
17.400   decreased-conc-annexinv-parkinsonian-csf.pdf
637.283   deletion-alloantigen-activated-cells-ala-pdt.pdf
57.052   delivery-ps-pdt.pdf
668.075   Dendritic Cells Injected Via Different Routes Induce Immunity.pdf
341.014   dendritic-pc-synthesis-photophysical-aggregation.pdf
289.587   Denileukin Diftitox (IL-2 toxin) downregs Tregs rejects breast cancer.pdf
438.030   Depletion of CXCR2 Inhibits Tumor Growth LuCa.pdf
264.935   Depolarizations of the Inner Mitochondrial.pdf
525.091   determination-activation-spectrum-alpc-meningioma-cells-.pdf
114.539   dexamethasone and Anti-IL-10.pdf
442.774   Dexamethasone Treg inhibition.pdf
241.732   DHA sodium butyrate.pdf
212.835   diabetes.pdf
137.314   diabetes2.pdf
484.502   Diethyldithiocarbamate can induce apoptosis and necrosis.pdf
293.938   Diethyldithiocarbamate Complexes against breast cancer.pdf
216.765   differential-responses-photosensitized-epithelial-vs-lymph.pdf
243.676   direct Apoptosis by immature DCs.pdf
298.562   direct kill by immature DCs TNF FASl Lymphotoxin alpha1 beta2.pdf
134.683   direct tumor damage PDT.pdf
906.907   DISCORDANCE AMONG CELL-MEDIATED CYTOLYTIC mechanisms.pdf
1.068.204   distribution-alpcs2-alpcs4-cell-populations-fibrosarcoma.pdf
357.378   DNA Fusion Vaccine.pdf
440.647   does-cyclosporine-inhibit-invivo-hepc-virus-replication.pdf
883.560   domain-dependent-photodamage-bcl2.pdf
755.217   DOWN REGULATION OF CYTOTOXIC IMMUNE RESPONSE.pdf
431.735   Downreg of HCF reduces LuCa.pdf
640.632   dynamic-fluorescence-changes-pdt-invivo-invitro-hydrophilic-alpc-lipophilic-znpc.pdf
974.646   ECM and PDT.pdf
587.078   effect-delivery-system-biodistribution-ge-octabutoxy-phthalocyanines-tumour-mice.pdf
440.895   effect-delivery-system-pharmacokinetic-phototherapeutic-bismethyloxyethyleneoxysipc-tumor-mice.pdf
1.021.976   effect-density-gradients-binding-ps-agents-plasma-proteins.pdf
619.707   effect-liposomal-formulations-znpc-isolated-ldl-hdl.pdf
640.614   effect-solvent-deuteration-photophysics-sulphonated-alpc.pdf
521.529   Effects of Silver Island Films on Fluorescence Intensity,.pdf
86.394   Effects of STAT3 silencing on fate of chronic ... [Leuk Lymphoma.pdf
123.768   effects-pdt-absorption-properties-alpcs2-tumor-bearing-mice.pdf
657.795   efficacy-mechanism-alpc-sulphonated-pdt-murine-tumours.pdf
133.869   elastography.pdf
110.651   Enhanced PDT with iron removal.pdf
280.676   enhanced-apoptotic-response-pdt-bcl2-transfection.pdf
465.901   enhanced-pd-effects-fractionated-laser-light.pdf
381.395   enhancement-us-cell-damage-pc-invitro.pdf
741.562   envhper00331-0188.pdf
443.913   Epigenetic Transdifferentiation of Normal Melanocytes by a Metastatic Melanoma Microenvironment 10164.pdf
1.265.591   Erythrocyte glutothione synthetase.pdf
334.060   escharotic-other-botanical-agents-treatment-skin-cancer.pdf
758.445   esr-superoxide-anion-hydroxyl-singlet-oxygen-photohemolysis.pdf
161.045   estrogen upregulates foxp3.pdf
163.876   evidence-based-photopheresis-1987-2001.pdf
890.708   evidence-important-role-neutrophils-efficacy-pdt-invivo.pdf
1.380.051   excited-triplet-photophysics-sulphonated-alpc-serum-albumin.pdf
24.608   Exogenous Glycation hazards.pdf
88.353   Expansion of Functional NK Cells in Multiple Tissue.pdf
470.272   extra and inter cellular pH.pdf
781.219   extracellular-fluid-carcinomas-immunosuppressive-adenosine.pdf
254.121   False pet scan inflammation macrophages.pdf
1.069.854   FAS and autoimmunity.pdf
680.768   FAS-l mediates TIL apoptosis.pdf
414.601   fat low frequency high intensity ultrasound.pdf
506.419   Fetoprotein (AFP)-Specific T Cell Responses Hepatocellular Cancer.pdf
126.811   fibrosis inhibition PDT.pdf
253.048   flavin-dca.pdf
1.064.170   Flavone Acetic Acid and IL-2.pdf
571.276   FLAVONE-8-ACETIC ACID IL-2 augments NKs.pdf
85.950   Flt3 ligand IL-2 boost NKs.pdf
386.327   fluorescence-guided-brain-tumour-resection-metronomic-pdt.pdf
768.994   fluorescence-guided-surgery-ala-malignant-glioma-phase3-trial.pdf
1.163.236   fluorescence-spectroscopy-intracellular-imaging-alpc.pdf
577.462   FluorescenceMicroscopyApplications.pdf
179.039   fluorimeter.pdf
292.189   folates.pdf
569.199   follistatin suppresses metastasis.pdf
193.164   fractionation to replace hyperbaric.pdf
268.997   fret-reveals-binding-site-photosensitizer-pdt.pdf
526.417   Functional Analysis of Antigen-Specific T Lymphocytes.pdf
753.632   fusion of OvCa and DCs immunity.pdf
179.594   G-CSF replaces crippled NKT cells.pdf
421.882   Galactose damage.pdf
409.680   gamma chain naive cd4 tcell survival.pdf
1.388.768   gc-e6 conjugate.pdf
254.170   gelonin enhanced pdt.pdf
474.296   Gene-Engineered T Cells as a Superior Adjuvant Therapy.pdf
162.868   GI cancer ala iron chelation.pdf
119.877   GI pdt.pdf
352.080   glioma lfu photofrin.pdf
141.370   Glucose BSO apoptosis.pdf
557.842   Glucose the safer alternative.pdf
959.104   glutathione in light fractionation.pdf
866.282   glycated chitosan.pdf
114.688   glycoconjugation phthalocyanine.pdf
1.137.218   glycol chitosan nano for lypophilic materials.pdf
1.237.906   glycol chitosan paclitaxel.pdf
1.152.112   glycolycin from 3BP ethanol methanol and 1 proponol.pdf
74.161   Glycosylceramides Enhance the Antitumor Cytotoxicity.pdf
178.072   GM csf.pdf
67.685   golden staph AlPc.pdf
126.580   golden staph SnCe6.pdf
66.042   golden+staph+AlPc.unlocked.pdf
1.185.862   gox cam wound healing.pdf
49.133   GOX chitosan.pdf
30.366   gox msds.pdf
255.555   guidelines-topical-pdt-update.pdf
634.253   GVH test for immunocompetence in cancer patients.pdf
397.803   gyceraldehyde in 3BP cell death.pdf
67.377   H2O2 LFU apoptosis.pdf
592.580   hamblin cationic and chain length pact.pdf
651.863   hamblin on immune response to PDT.pdf
651.863   Hamblin_Nature_Review_Cancer_2006.pdf
1.215.610   Hb photolysis.pdf
200.142   Head and neck cancer.pdf
252.504   head and neck zd6474.pdf
169.596   head and neck.pdf
850.978   healing flare.pdf
451.821   heat shock and DC's.pdf
191.052   heat shock immunity thermotherapy.pdf
75.394   hep b immunoassay antigen polymer.pdf
138.424   Hepatocellular Carcinoma-Associated Antigens.pdf
298.634   HER-2 mabs inhibit tumor growth.pdf
870.145   herpes-simplex-virus-proteins-damaged-pd-inactivation-pc.pdf
80.265   High pH Cancer Therapies.pdf
515.760   Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells.pdf
143.127   history-photodetection-pdt.pdf
244.639   HIV AlPc wainwright.pdf
159.950   HIV antibody properties vs glycosylation.pdf
979.230   HIV Ifn Gamma mod by IL2.pdf
476.564   HIV pc no light.pdf
788.068   HIV protection os CD4+ tcells.pdf
780.122   HIV viral inactivation in cell compositions.pdf
903.405   HIV- 1 -SPECIFIC B CELL ACTIVATION.pdf
554.716   HIV-1-Specific Mucosal CD81 Lymphocyte HIV resistance.pdf
270.413   HIV-Specific IL-10-Positive CD8+ T Cells Are Increased.pdf
237.469   hiv.pdf
851.451   HLA-A2 Restricted CTLs.pdf
168.330   HPV CeCa.pdf
102.738   HPV cervical cancer pdt.pdf
1.340.830   HPV MCH alleles CeCa PaCa ReCa CoCa Melanoma.pdf
239.246   hrp iaa anoxic.pdf
238.668   hsp110 or grp170 vaccines hyperthermia.pdf
111.487   httpwww.health-science-spirit.com borax.pdf
302.341   Human Chorionic Gonatrophin (HCG) Test.pdf
376.109   Human Hepatocellular Carcinoma in a Mouse Model 3bp.pdf
132.740   Human hepatocellular carcinoma in a mouse model assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists.pdf
650.609   hybrid phthalocyanines.pdf
159.867   hypericin.pdf
260.328   hyperthermia chlorophyl pdt.pdf
439.797   Hyperthermia Enhances CD95-Ligand in Tcells.pdf
313.845   Hypohomocysteinemia_MM_whitePaper.pdf
304.283   Hypoxia and Photofrin Uptake.pdf
1.468.424   hypoxic cell subpopulations in melanoma.pdf
34.432   I26_ANTIGEN_Ab_list.pdf
194.452   ib-cancer-2008-12-28-draft.pdf
196.925   ib-cancer-2009-02-03-draft.pdf
150.413   ib-cancer.pdf
195.563   icg chitosan pdt immunotherapy.pdf
600.431   ICG chitosan.pdf
387.865   Identification of CD4+ T Cell Epitopes from NY-ESO-1.pdf
341.429   IFG IL-10 suppression.pdf
90.945   IFN alpha enhances Th1 response.pdf
1.337.853   IFN-a treatment increases the expression of CD95.pdf
82.877   IFN-g- and Cell-to-Cell Contact-Dependent Cytotoxicity of.pdf
525.537   IFN-gamma and T-bet Expression in DCs.pdf
83.231   IFN-gamma crucial.pdf
257.477   igc tin chlorin e6 golden staff.pdf
217.257   IL 10 generates functional decoys.pdf
441.409   IL-1 IL-6 Cancer Cachexia.pdf
550.584   IL-10 and TGF-b in cancer-mediated immunosuppression.pdf
82.215   IL-10 CTLA-4 l-PAM tumor eradication.pdf
818.871   IL-10 increases IFN gamma.pdf
410.731   IL-10 mycobacterial.pdf
1.101.181   IL-10 regulates macrophages.pdf
550.584   IL-10 TH2 immunosuppression.pdf
929.357   IL-10.pdf
899.193   IL-10I nhibits IL-5-b ut not IL-2 Induced Ig Secretion.pdf
118.082   IL-12 Boosts CD8+ T Cells.pdf
98.109   IL-12 elicits tumor immunity.pdf
641.821   IL-13 Receptor-Targeted Cytotoxin complete eradication.pdf
135.517   IL-18 IgE Th2.pdf
391.644   IL-2 and GM-CSF most potent cytokines.pdf
174.903   IL-2 IL-12 IFN-gamma metastitic kills.pdf
1.613.575   IL-2 induces TNF IL-6 and Tac.pdf
579.229   IL-2 simian immundef virus resistance.pdf
1.257.545   IL-21 Enhances Tumor-Specific CTL Induction by Anti-DR5.pdf
119.999   IL-4 alloreactive CD4 T cells.pdf
623.502   IL-4 Protects Tumor Cells from Anti-CD95 and.pdf
1.206.844   il-6 il-10.pdf
364.436   IL-6 PDT.pdf
279.137   IL-6 STAT3 IL-10 immunosuppressive chain.pdf
444.912   IL-7 memory CD8 T cells.pdf
1.340.838   IL-8 ovarian.pdf
429.119   IL10 CD25 Treg overlap.pdf
198.484   IL15 anti cd40 complete remissions.pdf
345.764   IL6 and cancer.pdf
1.042.656   ILT3 induce CD8+ Treg.pdf
723.268   imaging CA cancer clin.pdf
777.740   ImationLOCKv108-BManual.pdf
642.934   immature myeloid cells inhibit Tcell responses cancer immunosuppression mechanism.pdf
397.080   immobilized-pc-red-light-ps.pdf
1.079.156   IMMUNE COMPLEXES IN HUMAN CANCER SERA.pdf
252.333   immune dysfunction.pdf
319.048   IMMUNE RESTORATION BY ClMETlDlNE IN VITRO.pdf
628.824   Immune-Suppressive IL-12p40.pdf
382.216   Immunoediting results in reshaping the immunogenicity of the tumor,.pdf
617.878   Immunological and Antitumor Effects of IL-23.pdf
92.778   immunological-consequences-pdt-cancer-literature-review.pdf
555.286   immunosuppressive IL-10, TGF-Beta, VEGF, M-CSF or IL-6 NK.pdf
127.962   immunotherapy of human cancer.pdf
360.448   improving PDT comprehensive sensitizer.pdf
141.117   In vitro study of low intensity ultrasound combined with different doses of PDT_ Effects on C6 glioma cells.pdf
285.219   inactivation-vascular-smooth-muscle-cells-ps-liposome-delivered-znpc.pdf
87.142   Increased levels of interleukin-10 and transforming gro... [BJOG.pdf
478.468   Increased NK does not cause remission in NSCLC.pdf
117.869   increasing Oxygen and Alkalinity in the Body.pdf
524.288   indocyanine green.pdf
293.150   indole-3-acetic acid.pdf
74.493   indole-3-acetic pdt.pdf
1.029.308   Induction of HIV-Specific Cytotoxic T cells.pdf
676.467   induction-apoptotic-cell-death-pdt-human-keratinocytes.pdf
106.622   Induction_of_cancer_specifi.pdf
913.020   Inefficient Cross-Presentation Limits the CD8+ T Cell Response.pdf
352.615   Inflammation Induces Myeloid-Derived Suppressor Cells.pdf
340.172   influence-depleted-glutathione-levels-photodynamic-znpc.pdf
474.512   influence-nh3-cl-no2-chloro-alpc-thin-films.pdf
425.651   influence-pdt-immune-response.pdf
1.231.602   Inhibition of Tumor Growth In Vivo by Death Receptor 4 mabs.pdf
1.516.054   initiation-apoptosis-versus-necrosis-aluminum-phthalocy.pdf
487.499   Innate Immune Dysfunction in HIV Infection.pdf
195.513   innate immunity DNA vaccines.pdf
96.690   insolubles delivery tween 60.pdf
1.360.729   insulin targetting.pdf
679.525   InTech-The_art_of_immobilization_using_biopolymers_biomaterials_and_nanobiotechnology.pdf
707.191   interaction-cremophor-el-human-plasma.pdf
681.527   interaction-pc-lipid-membranes-spectroscopic-functional-study-isolated-rat-liver-mitochondria.pdf
958.987   interactions-solutol-hs15-cremophor-el-plasma-lipoproteins.pdf
166.486   intercalation.pdf
226.628   interferons inducers russian study.pdf
123.361   interleukin 10 in cancer patientsi.pdf
470.272   intra vs inter cellular pH.pdf
344.593   intraluminal-treatment-oesophageal-tumours-pdt-mb.pdf
82.676   Inulin and its Suitability for Intravenous Administration in Man.pdf
69.794   inulin diet cancer.pdf
80.611   inulin nontoxic potentiation of cancer radiotherapy.pdf
69.794   inulin oligofructose anticancer therapy.pdf
296.859   inulin stability pH temp.pdf
163.359   inulin.pdf
163.359   inuline potentiation.pdf
533.505   invitro-interaction-znpc-liposomes-plasma-lipoproteins.pdf
194.910   invitro-pdt-melanoma-cell-lines-pc.pdf
1.369.673   invitro-ps-cellular-uptake-subcellular-locali-mace-alpcsx.pdf
466.574   invivo-absorption-spectroscopy-tumor-sensitizers-fs-white.pdf
466.574   invivo-absorption-spectroscopy-tumor-sensitizers-fs.pdf
989.926   invivo-absorption-spectrum-disulphonated-alpc.pdf
155.898   invivo-action-spectra-absorption-fluorescence-excitation-spectra-ps-pdt.pdf
51.377   IpCa higher success two wavelengths.pdf
68.245   Iron down-regulates macrophage anti-tumour ... [Clin Exp Imm.pdf
958.553   iron removal.pdf
986.546   isoprinosine immune restoration.pdf
156.036   iv-repeated-dose-toxicity-znpcs2p2-pdt-beagle-dogs.pdf
341.849   kinetic-equilibrium-incorporation-alpcs2-unilamellar-vesicles.pdf
574.053   l-glutamine amino acid selective mitochondrial gsh inhibition.pdf
676.201   laa apoptosis via h2o2.pdf
289.250   laser-properties-phthalocyanines.pdf
276.817   Leukotriene B4 antimicrobial.pdf
800.142   Lifelong Control of Pancreatic Tumor Progression.pdf
904.882   light dosimetry.pdf
220.731   light E field cellular mechanism.pdf
1.087.209   light-induced-effects-sulfonated-alpc.pdf
851.374   light-scattering-human-skin-comparison-znpc-photofrin2.pdf
715.206   limitations-monastral-blue-vascular-label-rapid-clearance.pdf
84.060   lipo znpc.pdf
180.224   lipoic low dose naltrexone pancreatic.pdf
355.738   liposome delivery mrsa.pdf
1.041.227   liposome-bound-znpc-mechanisms-cellular-uptake-ps.pdf
456.838   liposome-delivered-131i-labelled-znpc-radiodiagnostic-agent-tumours.pdf
516.928   Liver CA cat vs pet.pdf
898.164   local-pdt-znpc-experimental-model-intimal-hyperplasia.pdf
611.454   local-treatment-viral-disease-pdt.pdf
234.161   long-term-tumor-resistance-laser-photo-immunotherapy.pdf
356.300   loss of b cell memory HIV.pdf
104.382   Loss of IFN-gamma Production by Invariant NK T Cells in.pdf
520.217   low dose better.pdf
149.625   Low-frequency-ultrasound-can-heal-and-regenerate-body-tissues-1.pdf
311.958   LPS induces rapid IL-10 release by M-CSF.pdf
348.318   LuCa Ag recog by CD4+ T cells.pdf
86.406   LuCa CD86.pdf
73.479   LuCa cells Induce Monocytes to increase angiogenisis.pdf
398.995   LuCa DCs Blocked at Immature Stage.pdf
397.820   LuCa IFN-gamma-Dependent Antitumor Responses.pdf
770.977   LuCa IL-17 Enhances the Net Angiogenic Activity.pdf
100.998   LuCa Tregs inhibit Tcells.pdf
283.006   LuCa Vaccine.pdf
302.998   Ly49 CD8 Statin inflammation.pdf
764.933   Lymphokine-Activated Killer Effector Cells Recombinant IL-2.pdf
850.642   lymphoma apoptosis.pdf
675.193   MAB 17-1A CoCa Ag.pdf
120.035   mab targeting.pdf
190.416   mab-treatment-exposes-3-mech-clin-course-ms.pdf
767.053   MACROPHAGE ARGININE METABOLISM and NO Inhibit or Stim Cancer.pdf
77.956   madcow.pdf
139.650   MAGE-3 Peptide Presented by HLA-DR1 to CD4+ T Cells.pdf
23.023   mal-pdt-practice-treatment-protocol.pdf
696.341   malaria CD25.pdf
202.648   malaria.pdf
953.763   malignancies-atherosclerotic-plaque-diagnosis-laser-fluores.pdf
344.064   manganese SOD negative on apoptosis.pdf
470.272   Manipulating pH.pdf
177.611   mb-pdt-oral-lichen-planus.pdf
55.376   MDC.pdf
370.344   MDR inconsequential with PDT.pdf
247.717   Mechanism of Immune Dysfunction.pdf
278.860   mediators-peripheral-blood-neutrophilia-pdt-solid-tumors.pdf
485.503   Melanoma-Associated T Cell Epitopes for ImmTher.pdf
147.065   melanoma.pdf
60.897   melatonin increases IL1- decreases TNF.pdf
557.793   Membrane-Bound TNF Mediates Mephalan hepatotoxicity.pdf
999.424   metals and chelators.pdf
529.107   metastat PrCa DCs antigen specific CD8 and CD4.pdf
518.334   Metastatic Melanoma Lymphodepletion followed by PBMC.pdf
24.103   methacryloxypropyltrimethoxysilane msds.pdf
372.072   methoxyestradiol SOD inhibitor.pdf
224.861   methylated chitosan BBB paracellular transport.pdf
262.484   methylated chitosan laxative.pdf
343.314   metronomic-pdt-brain-tumours.pdf
345.654   Michelakis 08 Dichloroacetate_(DCA)_as_a_potential-metabolic_targeting.pdf
167.377   Microbial Poly-l-lysine Chlorin es toluidine blue rose bengal.pdf
652.758   Microsoft Word - Phthalocyanine photosensitizers for photodynamic therapy and methods for their use[1].pdf
81.966   microwave induced pdt.pdf
350.477   MIF or CD74 block slows prostate.pdf
109.670   missing in immunology.pdf
169.403   mitochondria and positive benefits of ROS.pdf
629.688   modified chitosan.pdf
887.825   modulation-light-delivery-pdt-brain-tumours.pdf
81.261   monitoring of cytolytic T Lymphocytes.pdf
324.727   monitoring-pc4-pdt-clinical-trials-cutaneous-tcell-lymphoma.pdf
570.307   Morphological Characterization of Photodynamic Therapy.pdf
67.685   mrsa AlPcS2.pdf
15.371   mrsa death stats us and canada.pdf
140.395   mrsa selectivity cationic ZnPc.pdf
134.773   mrsa.pdf
275.230   mu and kappa opioid actions naltrexone.pdf
1.490.616   muc-1 ctl's eradicate tumors.pdf
591.264   MUC1 IL-10neg accelerates Infl Bowel and moves toward CoCa.pdf
293.896   multi-drug resistance in cancer.pdf
112.444   multimodality treatment prostate.pdf
199.784   Multipeptide Vaccine for Melanoma.pdf
488.913   multispectral-fluorescence-imaging-system-photofrin-pdt-brain.pdf
450.099   nanomol porphyrin.pdf
651.989   nanoparticles in cancer.pdf
945.579   nanosec 20mm two.pdf
418.585   nanotech pdt CA Cancer J clin.pdf
19.212   NASA ADS_ Photodynamic therapy (PDT) of malignant tumors by photosensitzer photosens_ results of 45 clinical cases.pdf
824.456   NATURAL CYTOTOXICITY AND INTERFERON PRODUCTION.pdf
327.900   natural killer cell tolerance.pdf
206.777   natural killer cells in cancer therapy.pdf
1.531.688   Nature dogs vs humans cancer research.pdf
544.075   nature nanoparticles.pdf
141.625   nature partnering to produce apoptosis.pdf
265.251   Nature PDT mentions immunity.pdf
428.516   Nc Agg nonlinear optical properties.pdf
710.402   ncluf wound healing.pdf
1.406.725   new-trends-photobiology-time-resolved-fluorescence.pdf
140.935   niemann-pick-human-lymphoblasts-resistant-pc4-pdt-apoptosis.pdf
65.277   Nitric oxide induces the apoptosis of human BCR-ABL... [Leuk.pdf
767.997   nitric oxide.pdf
207.668   NK cell activating ligands.pdf
466.023   NK cells hematopoietic stem cells transplant.pdf
318.327   NK Cells TGF beta IL10 TRAIL.pdf
421.335   NK Cells Use NKG2D to Recognize a Mouse Renal Cancer.pdf
92.870   NKC massage.pdf
256.171   NKG2D receptor for tumor immunity.pdf
247.799   NKT cell repression of tumor immunity.pdf
93.151   NKT cells tumor immunity.pdf
116.985   NO impact on PDT.pdf
331.781   NO kidney.pdf
631.460   NO S-n ZnPC.pdf
204.050   NO SOD Laser Phthalocyanine.pdf
75.221   Non-Small Cell Lung Cancer Cells Induce Monocytes to.pdf
318.700   nonlinear absorption ZnPc.pdf
168.829   Novel Drug Form of Chlorin E6_2.pdf
113.239   novel therapies prostate.pdf
213.300   novel-water-soluble-phthalocyanines-substituted-phosphonate-moieties.pdf
465.521   NY-ESO-1-Derived Epitope Stimulates CD4+.pdf
511.513   OCR_Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells.pdf
164.938   One More PDT Application of Chlorin E6_2.pdf
421.772   opioid growth factor (OGF) enhances the growth inhibition.pdf
250.228   OpioidAntagonistsForPain.pdf
138.174   oral-ala-ppix-fluorescence-psoriatic-plaques.pdf
190.851   orotic acid salts study.pdf
1.068.642   OvCa HLA-A2 Shared Tumor-Associated antigens.pdf
191.564   overexpression-bclxl-prevents-caspase3-mediated-dff-bpdma.pdf
164.448   Oxford 172 patients survival.pdf
485.413   oxidant resistant NK's Tcells by Myeloid dendritic cells.pdf
277.560   oxidant resistant NK's.pdf
163.067   Oxidative Stress and electron transfer cancer.pdf
236.596   PACT wainwright.pdf
83.312   parkinsons autoimmune.pdf
573.440   PC in PDT.pdf
230.799   Pc polymer synthesis carboxylates.pdf
978.970   Pc sensitizers ligands.pdf
978.970   Pc synthesis and use multiple exposures for complete remission.pdf
1.114.382   pc-lipid-peroxidation-cell-membranes-cholesterol-azide-probes-photochemistry.pdf
79.353   PC4 approved med indications.pdf
75.303   PC4 GSH trolox molarity time power.pdf
142.624   PC4 liposomes HIV.pdf
204.754   pc4-pdt-u87-derived-human-glioma-nude-rat.pdf
1.151.564   PCa kills DCs Bcl-xl protects them.pdf
505.805   pd-activity-dibiotinylated-alspc-invitro-invivo.pdf
928.577   pd-inactivation-herpes-viruses-pc-derivatives.pdf
603.592   pd-inactivation-retroviruses-pc-sulphonation-metal-ligand.pdf
887.831   pd-properties-nsbp-asymmetric-amphiphilic-pc-deriv.pdf
236.596   PDT and antimicrobial PACT.pdf
103.817   pdt and emf.pdf
278.528   PDT and fluorescent imaging.pdf
122.855   PDT and radiation therapy.pdf
235.688   pdt annals of medicine.pdf
371.895   pdt apoptosis autophagy.pdf
78.364   pdt apoptosis melanoma.pdf
294.318   pdt apoptosis.pdf
597.954   pdt artery wall strength.pdf
229.001   PDT assisted immunotherapy.pdf
681.786   pdt aust j chem Phosphorous Triazatetrabenzocorroles.pdf
321.852   pdt bacteria.pdf
853.134   pdt bacteriophage.pdf
363.780   pdt bjc achievements.pdf
163.359   pdt bjc inulin.pdf
62.822   pdt bladder sciencedirect.pdf
105.436   pdt bowens.pdf
275.956   pdt brain.pdf
156.602   pdt cancer immunity.pdf
159.283   pdt cancer.pdf
108.816   pdt cevical neoplasia.pdf
588.041   pdt chemo.pdf
984.525   PDT complexities.pdf
457.601   PDT comprehensive.pdf
76.157   pdt cox-2 etc.pdf
466.739   pdt csiro azaphthalocyanine.pdf
316.500   pdt csiro hematoporphyrin.pdf
520.217   pdt csiro porphyrins and phthalocyanines.pdf
566.580   pdt csiro stentorin.pdf
566.760   pdt dentistry.pdf
176.423   pdt dougherty.pdf
511.038   pdt electrochemical lysis.pdf
188.674   pdt endobronchial.pdf
134.193   pdt endodontic.pdf
162.483   pdt endometriosis.pdf
905.655   pdt enhancement.pdf
242.545   pdt esophagus lung.pdf
247.280   pdt fluence hypxia and hyperbaric.pdf
568.812   PDT for epilepsy.pdf
394.847   pdt fundamentals.pdf
671.591   pdt gastro.pdf
1.277.513   pdt glioma.pdf
78.594   pdt head and neck.pdf
103.224   pdt host response.pdf
227.806   PDT immune dysfunction MS rheumatoic arthritis.pdf
438.660   PDT immune response angiosarcoma sciencedirect.pdf
425.651   pdt immune response.pdf
661.682   pdt immunity to cancer.pdf
64.860   PDT increases skin IL-10.pdf
120.488   pdt lancet immun.pdf
263.548   pdt leishmaniasis.pdf
193.684   PDT liposomes.pdf
131.735   pdt lung.pdf
200.073   pdt mab targeting.pdf
411.905   pdt mechanisms.pdf
389.154   pdt microvascular blood dynamics.pdf
128.666   pdt motexafin prostate.pdf
305.742   pdt mthp prostrate.pdf
134.496   pdt nasophyngeal adenocarcinoma.pdf
661.682   pdt nature cancer immunity.pdf
176.435   pdt oxford general.pdf
73.817   pdt photofrin barret's.pdf
718.030   pdt polymers.pdf
520.217   PDT porphyrins pthalocyanines general.pdf
118.960   pdt precancerous lesions.pdf
455.085   pdt protective autophagy glioma.pdf
193.540   pdt purging stops graft rejection sciencedirect.pdf
314.238   pdt rat glioma.pdf
220.972   pdt rbc platelets viral.pdf
323.402   PDT resistance.pdf
1.109.926   pdt royal society of medicine.pdf
181.332   pdt sarcomatosis.pdf
245.827   pdt scavenger receptor targeting.pdf
73.746   pdt silicon phthalocyanine.pdf
1.067.896   pdt sulphonation effect on uptake selectivity.pdf
767.036   pdt targeting.pdf
224.251   pdt timing.pdf
254.832   pdt tumor spheroids.pdf
561.022   pdt turkey 2002.pdf
20.147   PDT with AlPc.pdf
388.104   pdt-cerebral-glioma-review-pt1-biological-basis.pdf
185.269   pdt-cerebral-glioma-review-pt2-clinical-studies.pdf
25.649   pdt-dermatoses-other-than-nonmelanoma-skin-cancer.pdf
165.809   pdt-generated-vaccines-relevance-tumour-cell-death-expression.pdf
143.034   pdt-human-breast-cancer-xenografts-lacking-caspase3.pdf
57.632   pdt-immune-system-experimental-oncology.pdf
1.091.066   pdt-induced-death-hct116-cells-apoptosis-with-without-bax.pdf
119.268   pdt-intact-breast.pdf
68.716   pdt-novel-3rd-gen-photosensitizers-one-step-closer.pdf
1.076.742   pdt-phthalocyanine-photosensitizer-pc4.pdf
520.217   pdt-porph-pc-ps.pdf
171.632   pdt-pulsed-light-sources-theoretical-analysis.pdf
363.305   pdt-tumor-induced-angiogenic-vessels.pdf
164.448   pdt.pdf
225.447   pdz spectra kill depth.pdf
36.479   penetration vs wavelength.pdf
180.045   Perforin vs FAS pathways in Lysis by NK and T Cells.pdf
240.451   peripheral-benzodiazepine-receptor-pdt-phthalocyanine-pc4.pdf
118.963   PET scans Photofrin AlPcS2.pdf
70.499   PF BSA glioma.pdf
395.833   ph-dependence-fluorescence-absorbance-sulphonated-alpc.pdf
128.285   Phage targeting of SnChlorin e6 for MRSA not too good.pdf
435.798   Pharma manipulation of apoptosis and MOMP.pdf
65.811   phase1-pharmacokinetic-study-pdt-high-grade-gliomas-boron.pdf
248.916   Phenothiazines.pdf
194.957   Phenothiazinium Antimicrobial Photosensitizers Are Substrates of MDR pumps.pdf
196.793   Phenothiazinium PS substrates of Multidrug resistance pumps.pdf
193.093   Phospho-Stat3 (Tyr705) Antibody 9131.pdf
1.291.359   phospholipase apoptosis.pdf
11.076   phosphorus balance and cancer.pdf
702.581   photobleaching-diphenylisobenzofuran-novel-pc-dye-derivatives.pdf
905.464   photobleaching-sensitisers-pdt.pdf
423.787   Photochemical Targeting of Epidermal Growth Factor.pdf
554.188   photochemotherapy-experimental-colonic-tumours-intratumorally.pdf
273.276   photodamage-multiple-bclxl-isoforms-pdt-pc4.pdf
1.118.925   Photodynamic action of merocyanine 540 on artificial and natural.pdf
152.287   Photodynamic ALA cats SCC nasal.pdf
484.236   Photodynamic Inactivation of Pseudorabies Virus with.pdf
778.042   Photodynamic inactivation of viruses in cell-containing compositions.pdf
71.891   PHOTODYNAMIC THERAPY OF ARTERIES_ PRESERVATION OF MECHANICAL INTEGRITY.pdf
468.006   PHOTODYNAMIC THERAPY of cancer general.pdf
329.520   Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells.pdf
355.260   photodynamic-activity-bamsipc-unsymmetrical-bisamino-sipc.pdf
384.119   photofrin ascorbate squamous.pdf
430.303   photoimmunotherapy egfr.pdf
509.907   photoinactivation-bacteria-cationic-water-soluble-znpc-gram-negative-positive.pdf
275.346   photophys-photochem-znpc-long-time-circulation-micelles-pdt.pdf
713.548   photophysical-properties-ruthenium-substituted-pc.pdf
590.120   photophysics-photostability-zn-al-sulphonated-naphthalocyanines.pdf
1.551.218   photosense breast cancer.pdf
300.015   photosensitisation-ecoli-alpcs2.pdf
331.975   Photosensitization with Zinc (II) Phthalocyanine as a Switch in the Decision.pdf
152.931   Photosensitizer Binding to Lipid Bilayers as a Precondition for the.pdf
338.672   Photosensitizer-antibody conjugates for detection and.pdf
378.457   Photosensitizer-antibody%20conjugates%20for%20detection%20and.pdf
197.096   photosensitizers discussion.pdf
126.578   phthalocyanine clinical trial 2005.pdf
123.277   phthalocyanine clinical trial 2013.pdf
674.332   phthalocyanine conjugates.pdf
1.649.241   Phthalocyanine Photo Sensitizers for Photodynamic.pdf
121.150   phthalocyanines-covalently-bound-biomolecules-targeted-pdt.pdf
354.631   phytoadaptogen.pdf
520.135   placebo-controlled-study-ala-pdt-psoriasis.pdf
153.094   plasma-pharmacokinetics-tissue-distribution-cd2f1-mice-pc4.pdf
206.887   poly-l-lysine Ce6 conjugation.pdf
1.358.663   polycation chitosan.pdf
157.857   polyclonal vs monoclonal antibodies.pdf
223.801   polyion-complex-micelles-pdt-dendritic-ps-long-wavelength.pdf
220.395   polymer micells for PS delivery.pdf
236.335   Polymeric micelles for PS delivery AlClPc Cremophor.pdf
1.489.928   polymeric nanoparticle curcumin.pdf
206.613   Polymorphonuclear Granulocytes Induce Antibody-Dependent Apoptosis in BrCa.pdf
274.110   polyvinyl alcohol nanoparticle production details low liver accumulation.pdf
940.295   population NK and Treg malignant NSCLC.pdf
458.752   porphyrin nanoparticles PLGA.pdf
339.935   porphyrin synthesis phthalocyanines etc.pdf
365.693   Porphyrins_white_paper.pdf
1.024.118   Positive and negative regulation of Natural Killer.pdf
712.122   positron-emitting-radioisotopes-localization-brain-tumors.pdf
148.297   post salvage recurrence and cox-2.pdf
49.986   potassium carbonate.pdf
568.830   potentiation-anti-tumour-photofrin-pdt.pdf
1.423.811   potentiation-pdt-elicited-antitumor-response-gmcsf.pdf
94.131   PPC cationic e-coli cell membrane transport mechanism.pdf
160.535   ppi vs h2 blockers.pdf
1.064.387   PrCa Tolerization of Tumor-Specific T Cells.pdf
305.195   Predicting Tumor Outcome following Cancer Vaccination.pdf
738.270   preferential-photoinactivation-leukemia-alpc.pdf
680.500   preparation-photophysical-meas-perdeutero-znpc.pdf
296.170   preparation-water-soluble-fluorinated-znpc-pdt.pdf
1.271.450   present-future-role-pdt-cancer.pdf
679.221   production-o2minus-oh-irradiation-znpc.pdf
123.467   prostate adjuvant therapy con.pdf
71.682   prostate adjuvant therapy.pdf
86.744   prostate antigen recognition.pdf
337.025   Prostate cancer.pdf
48.674   prostate optical characteristics.pdf
985.722   prostate-pdt-dosimetry.pdf
117.669   prostrate pdt.pdf
1.212.364   protective-immunity-tumor-vaccines-requires-cd40-cd154.pdf
712.573   proteosome inhibitors.pdf
115.180   Ps binding to Lipid Bilayers AlPc(n).pdf
111.014   PS binding to lipid bilayers.pdf
591.048   PS enhance selectivity and efficiency of PDT.pdf
193.540   psa vaccine.pdf
133.102   Pseudomonasaeruginosa.pdf
483.430   psoriatic-plaques-red-autofluorescence-ppix.pdf
877.330   pulse intensity depth control.pdf
171.621   Pure Sensitiser.pdf
29.392   qlt autoimmune.pdf
357.532   radiation damage.pdf
162.778   radical prostatectomy remission vs gleason score.pdf
142.579   RANTES chemoattractant of immunity cells.pdf
622.555   rapamycin Treg expansion.pdf
437.080   rapid-cytochrome-c-release-hela-pdt.pdf
310.459   Reactivity of Tcells to Anaplastic Large Cell Lymphoma.pdf
88.412   Recognition of a Shared Human Prostate Cancer-Associated.pdf
390.915   Recombinant p21 Protein Inhibits Lymphocyte Proliferation.pdf
629.273   recovery-cho-ps-znoh4pc.pdf
129.149   reducing radiation damage.pdf
752.084   Regional Immunosuppression in Esophageal Squamous Cancer.pdf
1.099.378   regulatory IL-10 DC's.pdf
375.148   Reinstalling Antitumor Immunity by Inhibiting Tumor-Derived IDO immunosuppressor.pdf
67.353   Relevance of AG in Vacc strategies.pdf
66.549   Relevance of the Tumor Antigen in the Validation of Three.pdf
90.305   remission acute leukaemia natural killer cells..pdf
478.673   Rerouting lipoprotein nanoparticles to selected.pdf
398.923   Resistance to CD95-Induced Apoptosis in Hematopoietic Cancer Cell Lines.pdf
240.031   Response of naïve and memory CD8+ T cells.pdf
764.027   rhodium acetate.pdf
371.434   riboflavin malaria.pdf
143.074   RMH-pdt-high-grade-glioma-long-term-survival.pdf
1.528.233   Role of Tumor Cell Apoptosis in Tumor Antigen Migration.pdf
821.573   role-il1-gcsf-photofrin-pdt-rat-rhabdomyosarcoma(2).pdf
9.332   role-il1-gcsf-photofrin-pdt-rat-rhabdomyosarcoma.pdf
107.026   role-inflammation-neurodegenerative-diseases.pdf
836.905   role-ldl-recept pathway-delivery-lipophilic-ps-pdt-tumours.pdf
461.242   ROS-generating microsphere.pdf
318.429   ROSs H2O2 part of tumor-induced immune suppression.pdf
1.390.145   Royal Melbourne Glioma AlPc.pdf
547.633   salinomycin apoptosis.pdf
308.117   salinomycin leukemia.pdf
1.634.161   Salmonella Anti-IL10.pdf
414.991   scanning-laser-beam-ultrafast-pulse-laser-cleaning-paint.pdf
691.947   scatter vs localization.pdf
354.764   SDT - A review of research into the uses of low level ultrasound in cancer therapy (2).pdf
762.866   SECOND COMPONENT OF COMPLEMENT.pdf
145.030   selective-depletion-thymocyte-subset-iv-immuomodulatory.pdf
350.915   Selenium Caco.pdf
134.954   sensitivity-different-cell-lines-phototoxic-effect-alpcs2.pdf
134.730   sensitizer discussion.pdf
347.147   sensitizers comprehensive.pdf
416.293   sep-tetrasubst-phth-newly-dev-hplc-phases.pdf
345.078   SG phthalocyanines.pdf
570.914   Shift from Systemic to Site-Specific Memory IL-2.pdf
523.747   silicon phthalocyanine synthesis.pdf
223.360   siloxane PC nanoparticles.pdf
915.655   Simian AIDS loss of DC's.pdf
175.964   simple variables.pdf
131.046   single-neuron-response-pd-effect-al-zn-pc.pdf
538.802   SIV CD8 depletion.pdf
257.477   SnCe6 IgG mrsa.pdf
254.582   Sodium Stibogluconate in Synergy with IFNs.pdf
98.905   solutions and films of glycated chitosan.pdf
274.273   SOX-4 as a Lung Tumor Vaccine Antigen.pdf
405.246   SPECIFICITY OF CYTOTOXIC HETEROLOGOUS ANTISERUM.pdf
271.163   spectroscopic-evidence-monomeric-alpcs4-aqueous-solns.pdf
234.811   Spontaneous CD4+ T Cell Responses against TRAG-3.pdf
764.632   Staph Serotherapy.pdf
242.167   stat 3 hnscc.pdf
584.476   STAT3 abnormal DC differentiation.pdf
98.700   STAT3 silencing inhibits glioma single cell infi... [Neuro Oncol.pdf
171.060   state-of-the-art-delivery-ps-pdt.pdf
59.916   stattic stat3 inhibitor.pdf
633.429   steady-state-time-resolved-spectroscopic-studies-znpc-liposomes.pdf
312.044   StemEnhanceStudy.pdf
986.262   stereochemical-factors-transport-binding-ps-biological-systems-pdt.pdf
715.868   Streptococcal Preparation OK-432 Ag specific CTL CoCa.pdf
211.155   streptokinase complement activation.pdf
146.424   study-99mtc-annexinv-uptake-apoptotic-cell-models-parkinsons.pdf
368.522   subcellular-distribution-phototoxicity-alpc-hpd.pdf
240.343   substituents-tetrasubst-Pc.pdf
112.146   sulfonated-pc-photophysical-properties-in-vitro-uptake-structure-activity.pdf
112.146   sulfonated-pc-photophysical-properties-in-vitro.pdf
176.653   sulfonation thionyl chloride water precip pure.pdf
423.111   sunscreen-enhancement-uv-induced-ros-skin.pdf
815.454   suppressing haematogenous dissemination.pdf
470.231   Suppression of Antitumor Immunity by IL-10 and TGF-beta Tcells.pdf
731.690   SUPPRESSION OF THE RESPONSIVENESS OF LYMPHOCYTES FROM CANCER.pdf
388.263   survivin protects cancer from Fas apoptosis and attacks immune cells with Fas Ligand.pdf
590.915   SV40 T Ag short peptide complete liver tumor regression.pdf
15.808   Synthesis of phthalocyanines for photodynamic therapy.pdf
341.878   synthesis-fluorescence-singlet-oxygen-water-soluble-cationic-gapc.pdf
786.612   synthesis-pd-potential-tetra-octa-triethyleneoxysulfonyl-znpc.pdf
909.963   synthesis-properties-cationic-water-soluble-phthalocyanines.pdf
70.052   synthesis-size-tunable-upconversion-nanophosphors-consistent-shape-pdt.pdf
71.456   synthesis-water-soluble-octa-cationic-phthalocyanine-pdt.pdf
349.212   synthesis-znpc-derivatives-methoxy-trifluoromethylben.pdf
507.801   systemic-pdt-ala-apoptosis-lesional-tcell-psoriasis.pdf
112.642   T cell depletion in HIV-1.pdf
956.121   T Cell Localization, Activation, and Function in Progressive BrCa.pdf
94.218   T Cell-Derived IL-10 Promotes Lung Cancer Growth.pdf
731.690   T suppressors.pdf
428.816   tadlafil arganine nos.pdf
767.036   target specific.pdf
1.077.048   TARGETING ACTIVATED LYMPHOCYTES WITH PDT.pdf
1.133.439   Targeting unidentified PrCa Ags.pdf
369.178   tax basicsBUS25193n19080711.pdf
219.239   TB antimicrobial.pdf
450.599   TB mb.pdf
426.555   tcell death.pdf
83.948   tea reduces IL-10 and TGF-beta.pdf
561.693   telomerase and replication.pdf
341.339   testosterone-psa-stimulate-ros-prostate-cancer-cells.pdf
404.270   TGF beta induces Foxp3+ Treg.pdf
260.076   TGF beta NKG2D impairs NK cytotoxity in cancer.pdf
270.427   TGF-beta IL-10 colitis.pdf
849.733   TGF-Beta IL-10.pdf
94.323   TGF-beta neutralization enhances immunity.pdf
197.058   Th2 inflammation repressed by chemokines.pdf
80.839   The fight .pdf
149.678   The First Experience of Photodithazine Clinical Application For Photodynamic Therapy of Malignant Tumors_2.pdf
292.483   thioredoxin upreg.pdf
138.485   thymocytes and leukemia.pdf
18.034   Time to rethink prophylactic Mastectomy.pdf
720.319   time-gated-fluo-spec-porphyrin-deriv-alpc-invivo-murine.pdf
146.705   time-resolved-fluorescence-imaging-ps-mammalian-cells-ps-line-scanning-microscope.pdf
180.876   time-resolved-fluorescence.pdf
320.537   TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells.pdf
908.435   TLR9 abolished by HPV16.pdf
373.449   TNF alpha increases invasiveness of Epithelial Cancer.pdf
929.130   TNF alpha paradox explanation.pdf
460.340   Tnf Treg paradox.pdf
596.951   TNF-alpha inhibits macrophage clearance of apoptotic cells.pdf
268.601   topical-ala-pdt-psoriasis.pdf
146.709   tpa-cross-section-aluminium-phthalocyanine-fs-ti-sapphire.pdf
33.528   tramadol vs morphine.PDF
158.010   tramadolo-nk.pdf
369.412   transferin artemisinin.pdf
408.379   transient-reduction-fluorescence-alpcs4-tumours-pdt.pdf
368.112   transmembrane chemokines.pdf
476.167   Trastuzumab Conformational Epitopes.pdf
441.684   Treg 1.pdf
404.146   Treg 2.pdf
134.251   Treg 3.pdf
123.378   Treg 4.pdf
101.101   Treg inhibits autologous T cells.pdf
508.099   Treg suppression.pdf
493.116   Tregs high in tumor and blood of prostate cancer.pdf
335.493   tregs susceptible to apoptosis.pdf
138.467   triple-state-properties-tetrasubstituted-znpc-deriv.pdf
166.444   triplet-state-photophysics-alpc-sensitizer-murine-cancer.pdf
412.341   tumor Ags.pdf
572.924   tumor associated macrophages poor prognosis.pdf
755.455   tumor drug rejection by physical flows nanoparticle design.pdf
299.990   Tumor Gene WT1.pdf
1.322.953   tumor inhibition glutathione depletion ATP.pdf
166.409   tumor specific CD4 Tl's optimize induction of CTL's.pdf
245.124   Tumor Suppressor in Lung Cancer.pdf
432.026   Tumor-Specific CD4+ T Cells Activated by Cross-Dressed DCs.pdf
337.436   Tumoricidal Activity of Monocyte-Derived Dendritic Cells.pdf
602.806   tumour spheroid Cancer Cell internat.pdf
836.154   tumour-localizing-tumour-ps-properties-zn-octapentyl-pc.pdf
93.419   Tx BrCa w fibroblasts.pdf
179.400   type-i-type-ii-photoprocesses-photosense-ascorbic-acid.pdf
531.032   UDCA photofrin.pdf
154.468   UDCA potentiation of PDT.pdf
127.912   udca.pdf
403.100   UltimateCancerBreakthroughs.pdf
927.028   ultrastructural-changes-tritrichomonas-foetus-alpcs4-pdt.pdf
87.164   Up-regulation of hexokinaseII in myeloma cells targeting myeloma cells with 3-bromopyruvate.pdf
309.898   uptake dosimetry.pdf
638.604   UrCa.pdf
228.313   ursodeoxycholic acid mechanism.pdf
176.938   US Scientists Find That Chemotherapy Boosts Cancer Growth.pdf
812.872   utilization-endogenous-cellular-transport-delivery-therapeutics-blood-brain-barrier.pdf
776.790   UV produces IL-10.pdf
441.882   vaccine skin reaction without anaphylaxis.pdf
298.885   Variant Peptides Reverse onresponse of T Lymphocytes.pdf
387.411   Vascular Adhesion Protein 1 Mediates Binding of Teff to Endothelium.pdf
1.077.799   veg-f vpf uptake.pdf
220.972   Viral inactivation including HIV.pdf
136.109   Viral inactivation PC's Trolox electrolyte leakage.pdf
871.768   viral transfection Ag.pdf
486.075   Vital targeting strategy re-routes LDL from normal LDLR, should spare liver.pdf
93.540   vitamin d stem cells.pdf
468.691   vitamin d toxicity.pdf
112.879   vitamin k.pdf
401.545   vitamin-e-enhances-pdt-hpd-cervical-cancer-cells.pdf
665.488   VitDProstateCancer.pdf
1.190.340   VitE succinate.pdf
154.835   Water-soluble aluminium phthalocyanine.pdf
866.040   water-soluble-metal-naphthalocyanines-near-ir-ps-cellular-uptake-toxicity-ps-nhik3025-human-cancer.pdf
1.109.175   weylan3nasahealing.pdf
552.858   whey plus chemo.pdf
262.436   Wild-Type p53 Function1 induces CD95.pdf
120.113   wound healing acceleration.pdf
506.148   Yeast b-Glucan amplifies tumor killing by phagocytes.pdf
187.084   yield-intersystem-crossing-pc-time-resolved-photothermal-method.pdf
105.140   zinc phtalocyanine.pdf
540.821   Zn PPIX.pdf
293.429   ZnPc hemolysis.pdf
398.413   ZnPc nanomolecules.pdf
898.164   ZnPc restenosis.pdf
602.004   ZnPc Toxicity study.pdf
331.181   ZnPc(2) mitochondrial relocalization.pdf
286.164   znpc-cutaneous-diseases-ps-fibroblasts-keratinocytes.pdf
618.708   ZnPcS4 vs ZnNcS4.pdf
151.489   znpcs4-new-photosensitizer-pdt-choroidal-neovascularization.pdf
9.978   [Optimization of _Photosens_ pharmakokine... [Antibiot Khimioter. 2001] - PubMed - NCBI.pdf


Google

 

For an alternative view on the cause of cancer, click here
For a link to videos visit https://plus.google.com/106899184317319889581/posts/6yAhNHw3CjH